The Efficacy and Safety of Apatinib and Anlotinib in Advanced Non-Small Cell Lung Cancer.
Xiao WeiYun ZhaoWenyue YanQigang DaiHui WuYang MiaoLei HuangQing LiuXuyao ZhangHongxia WangYanan LiuLinlin ZhangPublished in: OncoTargets and therapy (2024)
Anlotinib demonstrated greater efficacy and safety compared to apatinib in the treatment of advanced NSCLC, particularly in patients with bone metastases and EGFR(-).